3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.Advanced Breast Cancer; ER-positive Breast Cancer; ESR1 Gene Mutation; HER2-negative Breast CancerRecruitingPhase 32026-08-24NCT06382948
Evaluation of Rapid Diagnostic Device for the Detection of Candida AurisCandida auris infection, Disease Attributes, Infections, Infections, Hospital, Pathologic Processes, Pathological Conditions, Signs and Symptoms, iatrogenic disease, immune system disorder, nosocomial infectionRecruitingNot stated2026-06-24NCT07253311
SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA StudyArterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorderActive, not recruitingNot applicable2025-09-23NCT04776434